We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Urinary Volatiles Used for Tuberculosis Diagnosis

By LabMedica International staff writers
Posted on 15 Aug 2011
Print article
A wide array of molecules is present in urine which can be measured and reflect the pathophysiological condition of an infected patient.

The volatile organic compounds (VOCs) in human urine derived from patients with tuberculosis (TB) and healthy controls can be identified and quantified using headspace gas chromatography/mass spectrometry (GC/MS).

Scientists at the International Center for Genetic Engineering and Biotechnology (New Delhi, India) tested the urine samples from 117 newly diagnosed TB patients and 37 controls with no history of TB or other chronic disease. Seven patients with similar pulmonary diseases like lung cancer and five with chronic obstructive pulmonary disease were also recruited.

The scientists found that infection with TB produces a distinct pattern of certain VOCs in much the same way that distinct fingerprint patterns can identify individuals. Identification of these patterns sets the stage for developing a portable "electronic nose" that can quickly sniff urine samples to detect TB. Five marker molecules were selected that showed high discriminatory power for TB diagnosis. Isopropyl acetate and o-xylene showed significant increase in abundance in the urine of TB subjects. Molecules like cymol, 2,6-dimethystyrene, and 3-pentanol showed significant decrease in abundance in urine of TB patients.

Patients undergoing treatment showed a variation in the urine VOC profile in comparison to untreated patients and healthy controls. The patients undergoing early and late treatment phase also showed significant class separation, and this may be due to the alteration in the overall metabolic activity induced by the drugs used in therapy. The authors concluded that a major advantage of the proposed method is the noninvasive nature of urine collection. Urine is a comparatively safer matrix as compared to sputum and painless in collection as compared to blood. The study was published on July 15, 2011, in the journal Analytical Chemistry.

Related Links:
International Center for Genetic Engineering and Biotechnology



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Celiac Disease Test
AESKULISA tTg-A New Generation
New
Crypto + Giardia One Step Combo Card Test
CerTest Crypto + Giardia

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.